116308-55-5Relevant articles and documents
Use of dihydropyridine derivatives for the prophylaxis or treatment of cerebral circulation disorders
-
, (2008/06/13)
A cerebral hyperkinemic composition which containa as an effective ingredient at least a dihydropyridine derivative of the general formula wherein R1, R2 and R3, which are identical or different, independently represent an alkyl, a cycloalkyl or an
Dihydropyridine derivatives for the treatment of angiospasm
-
, (2008/06/13)
A treating agent of angiospasm is disclosed, which contains, as an active ingredient, a dihydropyridine derivative represented by formula (I): wherein R1, R2 and R3 which may be the same or different, each represents an alkyl group or an alkoxyalkyl group; R4 and R5, which may be the same or different, each represents a hydrogen atom, a halogen atom, a nitro group, a halogenated alkyl group, an alkyl-sulfonyl group, a halogenated alkoxyl group, an alkylsulfinyl group, an alkyl group, an alkoxyl group, a cyano group, an alkoxycarbonyl group or an alkylthio group, provided that R4 and R5 do not simultaneously represent a hydrogen atom; X represents a vinylene group or an azomethine group; A represents an alkylene group ; and B represents -N(R6)2 or wherein R6 and R7 each represents a hydrogen atom, an alkyl group, an aralkyl group, an aryl group or a pyridyl group; Ar represents an aryl group or a pyridyl group; and n represents 0 or an integer of 1 or 2, or a pharmaceutically acceptable acid addition salt thereof. The agent exhibits high angiospasm inhibitory activity and extremely low toxicity.
